47 related articles for article (PubMed ID: 31691043)
1. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries.
Farioli A; Straif K; Brandi G; Curti S; Kjaerheim K; Martinsen JI; Sparen P; Tryggvadottir L; Weiderpass E; Biasco G; Violante FS; Mattioli S; Pukkala E
Occup Environ Med; 2018 Mar; 75(3):191-198. PubMed ID: 29133597
[TBL] [Abstract][Full Text] [Related]
2. Pesticide exposure and risk of cholangiocarcinoma: A hospital-based matched case-control study.
Pugkhem A; Kamsa-Ard S; Kamsa-Ard S; Luvira V; Luvira V; Bhudhisawasdi V
Trop Med Int Health; 2024 May; 29(5):390-404. PubMed ID: 38481371
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Incretin-Based Medications on Lipid Metabolism.
Yaribeygi H; Maleki M; Butler AE; Jamialahmadi T; Sahebkar A
J Diabetes Res; 2021; 2021():1815178. PubMed ID: 35005028
[TBL] [Abstract][Full Text] [Related]
4. Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons.
Kohli SC
Nepal J Epidemiol; 2016 Jun; 6(2):553-556. PubMed ID: 27774341
[No Abstract] [Full Text] [Related]
5. Advances in incretin-based therapeutics for obesity.
Rosenkilde MM
Nat Rev Endocrinol; 2024 Feb; 20(2):67-68. PubMed ID: 38062121
[No Abstract] [Full Text] [Related]
6. Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study.
Shin CM; Kim N; Han K; Kim B; Jung JH; Oh TJ; Lee DH
Cancer Epidemiol; 2020 Feb; 64():101658. PubMed ID: 31887708
[TBL] [Abstract][Full Text] [Related]
7. The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence.
Sun H; Qi X
Discov Oncol; 2022 Aug; 13(1):70. PubMed ID: 35933633
[TBL] [Abstract][Full Text] [Related]
8. Regenerative medicine of pancreatic islets.
Arutyunyan IV; Fatkhudinov TK; Makarov AV; Elchaninov AV; Sukhikh GT
World J Gastroenterol; 2020 Jun; 26(22):2948-2966. PubMed ID: 32587441
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis.
Howse PM; Chibrikova LN; Twells LK; Barrett BJ; Gamble JM
Am J Kidney Dis; 2016 Nov; 68(5):733-742. PubMed ID: 27528374
[TBL] [Abstract][Full Text] [Related]
10. Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus.
Campbell RK
Clin Ther; 2011 May; 33(5):511-27. PubMed ID: 21665040
[TBL] [Abstract][Full Text] [Related]
11. Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control study in a population of subjects with type 2 diabetes.
Giorda CB; Picariello R; Tartaglino B; Nada E; Costa G; Gnavi R
Acta Diabetol; 2020 Apr; 57(4):401-408. PubMed ID: 31691043
[TBL] [Abstract][Full Text] [Related]
12. Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study.
Giorda CB; Picariello R; Nada E; Tartaglino B; Marafetti L; Costa G; Gnavi R
Lancet Diabetes Endocrinol; 2014 Feb; 2(2):111-5. PubMed ID: 24622714
[TBL] [Abstract][Full Text] [Related]
13. Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.
Ueda P; Wintzell V; Melbye M; Eliasson B; Svensson AM; Franzén S; Gudbjörnsdottir S; Hveem K; Jonasson C; Svanström H; Pasternak B
Diabetologia; 2021 Oct; 64(10):2204-2214. PubMed ID: 34254177
[TBL] [Abstract][Full Text] [Related]
14. Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.
Soranna D; Bosetti C; Casula M; Tragni E; Catapano AL; Vecchia CL; Merlino L; Corrao G
Diabetes Res Clin Pract; 2015 May; 108(2):243-9. PubMed ID: 25748827
[TBL] [Abstract][Full Text] [Related]
15. Incretin-Based Therapies and the Short-term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies.
Boniol M; Franchi M; Bota M; Leclercq A; Guillaume J; van Damme N; Corrao G; Autier P; Boyle P
Diabetes Care; 2018 Feb; 41(2):286-292. PubMed ID: 29146599
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
